Nuvation Bio Inc. (NUVB)
USD 2.61
(-7.12%)
USD 2.61
(-7.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -67.99 Million | -96.1 Million | -68.19 Million | -36.52 Million | -24.43 Million | -616 Thousand |
| Net Income | -75.8 Million | -104.19 Million | -86.84 Million | -41.65 Million | -33.55 Million | -992 Thousand |
| Depreciation & Amortization | 222 Thousand | 199 Thousand | 184 Thousand | 103 Thousand | 13 Thousand | - |
| Deferred income taxes | -21.1 Million | - | 442 Thousand | - | - | - |
| Stock-based compensation | 19.51 Million | 16.29 Million | 9.26 Million | 2.2 Million | - | - |
| Change in working capital | 540 Thousand | -3.44 Million | 4.79 Million | 2.11 Million | -460 Thousand | 265.33 Thousand |
| Other non-cash items | 8.63 Million | -4.95 Million | 3.97 Million | 715 Thousand | 9.56 Million | 110.66 Thousand |
| Investing Cash Flow | 8.92 Million | 63.45 Million | -454.66 Million | -70.32 Million | -115.85 Million | - |
| Investments in PPE | -69 Thousand | -370 Thousand | -282 Thousand | -145 Thousand | -659 Thousand | - |
| Acquisitions | 14 Thousand | 13 Thousand | 454.66 Million | -2.5 Million | - | - |
| Investment purchases | -703.37 Million | -520.3 Million | -609.3 Million | -143.28 Million | - | - |
| Sales/Maturities of investments | 712.34 Million | 584.12 Million | 154.91 Million | 73.11 Million | - | - |
| Other Investing Activities | 8990.00 | 63.82 Thousand | -454.66 Million | 2.5 Million | -115.19 Million | - |
| Financing Cash Flow | 628 Thousand | 1.32 Million | 625.52 Million | 133.13 Million | 143.61 Million | 800 Thousand |
| Debt repayment | - | - | - | - | -14.99 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 628 Thousand | 1.32 Million | 625.52 Million | 135.65 Million | - | - |
| Other Financing Activities | 628 Thousand | 1327.00 | 624.76 Million | -2.52 Million | 128.62 Million | 800 Thousand |
| Accounts receivables | -1.21 Million | 554 Thousand | -1.94 Million | -264 Thousand | - | - |
| Accounts payables | 70 Thousand | -1.78 Million | 1.86 Million | 34 Thousand | - | - |
| Inventory | - | -554 Thousand | 1.94 Million | 264 Thousand | - | - |
| Other working capital | 1.68 Million | -1.66 Million | 2.93 Million | 2.07 Million | -460 Thousand | 265.33 Thousand |
| Cash at beginning of period | 101.09 Million | 132.42 Million | 29.75 Million | 3.46 Million | 137.86 Thousand | - |
| Cash at end of period | 42.64 Million | 101.09 Million | 132.42 Million | 29.75 Million | 3.46 Million | 184 Thousand |
| Capital Expenditure | -69 Thousand | -370 Thousand | -282 Thousand | -145 Thousand | -659 Thousand | - |
| Effect of forex changes on cash | 67.99 Million | - | - | - | 138.00 | - |
| Net cash flow / Change in cash | -58.45 Million | -31.32 Million | 102.66 Million | 26.28 Million | 3.33 Million | 184 Thousand |
| Free Cash Flow | -68.06 Million | -96.47 Million | -68.47 Million | -36.67 Million | -25.09 Million | -616 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -462.49 Million | -14.79 Million | -13.78 Million | -75.8 Million | -19.64 Million | -20.64 Million |
| Depreciation & Amortization | 244 Thousand | 58 Thousand | 55 Thousand | 222 Thousand | 55 Thousand | 56 Thousand |
| Deferred income taxes | - | - | -4.66 Million | -21.1 Million | -3.81 Million | -2.85 Million |
| Stock-based compensation | 9.56 Million | 5.04 Million | 3.72 Million | 19.51 Million | 5.43 Million | 5.52 Million |
| Change in working capital | -6.12 Million | -4.6 Million | -1.44 Million | 540 Thousand | 1.82 Million | 451 Thousand |
| Other non-cash items | 434.28 Million | 4.11 Million | 1.08 Million | 8.63 Million | -3000.00 | -18 Thousand |
| Investing Cash Flow | 34.27 Million | 7.54 Million | 33.16 Million | 8.92 Million | -9.59 Million | 37.34 Million |
| Investments in PPE | - | -27 Thousand | -13 Thousand | -69 Thousand | -22 Thousand | -22 Thousand |
| Acquisitions | 12.52 Million | - | 14 Thousand | 14 Thousand | 9570.00 | -37.36 Thousand |
| Investment purchases | -93.53 Million | -128.4 Million | -148.73 Million | -703.37 Million | -110.83 Million | -206.83 Million |
| Sales/Maturities of investments | 115.28 Million | 135.97 Million | 181.9 Million | 712.34 Million | 101.26 Million | 244.2 Million |
| Other Investing Activities | 21.75 Million | 7.54 Million | -1.00 | 8990.00 | -9570.00 | 37.36 Thousand |
| Financing Cash Flow | 2.74 Million | 21 Thousand | 120 Thousand | 628 Thousand | 77 Thousand | 133 Thousand |
| Debt repayment | -713 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.03 Million | 21 Thousand | 120 Thousand | 628 Thousand | 77 Thousand | 133 Thousand |
| Other Financing Activities | 2.74 Million | 21 Thousand | 120.00 | 628 Thousand | 77.00 | 133.00 |
| Accounts receivables | 272 Thousand | -581 Thousand | -669 Thousand | -1.21 Million | -238 Thousand | -522 Thousand |
| Accounts payables | -3.01 Million | 227 Thousand | -164 Thousand | 70 Thousand | -204 Thousand | -368 Thousand |
| Inventory | - | - | -548 Thousand | - | 238 Thousand | 522 Thousand |
| Other working capital | -3.37 Million | -4.25 Million | -608 Thousand | 1.68 Million | 2.03 Million | 819 Thousand |
| Cash at beginning of period | 34.51 Million | 42.64 Million | 24.39 Million | 101.09 Million | 50.06 Million | 30.07 Million |
| Cash at end of period | 34.28 Million | 34.51 Million | 42.64 Million | 42.64 Million | 24.39 Million | 50.06 Million |
| Capital Expenditure | - | -27 Thousand | -13 Thousand | -69 Thousand | -22 Thousand | -22 Thousand |
| Effect of forex changes on cash | 78 Thousand | - | 1.00 | 67.99 Million | - | - |
| Net cash flow / Change in cash | -225 Thousand | -8.13 Million | 18.25 Million | -58.45 Million | -25.67 Million | 19.99 Million |
| Free Cash Flow | -37.32 Million | -15.72 Million | -15.04 Million | -68.06 Million | -16.17 Million | -17.5 Million |
HUSQ-A
ROCK-B
PGEN
AS
ACUC
DMB